Nutraceutical Business Review Nutraceutical Business Review
  • Home
  • Ingredients
  • Research & Development
  • Manufacturing
  • Packaging
  • Events
  • Directory
  • Active Nutrition
  • Cardiovascular
  • Digestion
  • Cognitive
  • Finance
  • Regulatory

Kaneka Nutrients Europe

www.kaneka-ubiquinol.com

2-3-18 Nakanoshima
Kita-Ku
Osaka
J-530-8288
Japan

+81 6 6226 5050

Activities

Ingredients | Medical Devices | Active Nutrition | Food

Related Companies

  • PLT Health Solutions
  • Lallemand Health Solutions
  • Nektium Pharma
  • Nutriventia
  • Beneo
  • KLK OLEO
  • Kappa Bioscience
  • PhytoGaia
  • Gencor
  • Euromed SA
  • Indena
  • Kemin
  • Sabinsa
  • Genosa
  • ActivInside
  • JRS Pharma
  • Faravelli
  • Natac
  • Giellepi
  • Ingredia

Related Content

Exploring the potential of probiotics in the treatment of IBS
Exploring the potential of probiotics in the treatment of IBS
Supporting mitochondria naturally and efficiently
Supporting mitochondria naturally and efficiently
The power of life: Healthy aging with Ubiquinol
The power of life: Healthy aging with Ubiquinol
Research supports Kaneka probiotic formulation for infant FGID
Research supports Kaneka probiotic formulation for infant FGID
The ultimate health combination: ubiquinol and mitochondria
The ultimate health combination: ubiquinol and mitochondria
Kaneka probiotic reduces LDL cholesterol levels
Kaneka probiotic reduces LDL cholesterol levels
Kaneka probiotics exhibit positive effect in COVID outpatients
Kaneka probiotics exhibit positive effect in COVID outpatients
Kaneka introduces Ubiquinol finished product concepts
Kaneka introduces Ubiquinol finished product concepts
Ubiquinol supplementation may help fight healthcare fatigue
Ubiquinol supplementation may help fight healthcare fatigue
Astaxanthin and ubiquinol: the mighty mitochondrial duo
Astaxanthin and ubiquinol: the mighty mitochondrial duo
Kaneka supplement business announces name change
Kaneka supplement business announces name change
Nutraceutical firms discuss growth and potential of immune segment
Nutraceutical firms discuss growth and potential of immune segment
Four probiotics evaluated in outpatients with COVID-19
Four probiotics evaluated in outpatients with COVID-19
COVID-19: Nutraceutical players respond
COVID-19: Nutraceutical players respond
Kaneka Innovation Award progresses to Phase 2
Kaneka Innovation Award progresses to Phase 2
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company